CMPX   $1.83  -1.08% Market Closed After Close 1.82 -0.55%

Compass Therapeutics Inc.
Total Cash 146.23M
totalCashPerShare 1.063
EBITDA -54.50M
Total Debt 1.09M
quickRatio 15.381
currentRatio 16.151
Total Revenue 850.00K
debtToEquity 0.745
Revenue/Share 0.006
ROA -0.20583999
ROE -0.30053
grossProfits
freeCashflow -23.76M
operatingCashflow -42.92M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -17.7
profitMargins 0.0
enterpriseValue 109.40M
forwardPE -3.6274512
floatShares 88.57M
sharesOutstanding 137.59M
sharesShort 2.49M
sharesShortPriorMonth 1.86M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.72%
Short Ratio help_outline 5.14%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 1.062
Price To Book help_outline 1.74
earningsQuarterlyGrowth
netIncomeToCommon -47.24M
trailingEps -0.35%
forwardEps -0.51%
enterpriseToEbitda -2.01
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.11 3Q 2024
institutionsCount 113
lastUpdated Oct. 22, 2024, 4:58 a.m.